Evidence map›Paper›PMID 30467418›Full record

ArticleCellular & molecular immunology2019

Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16.

Yan Li, Shihao Chen, Yafei Chi, Yiran Yang, Xiwen Chen, Huating Wang, Zhe Lv, Jingjing Wang, Linjie Yuan, Ping Huang and 4 more

Abstract read
In one paragraph

Article in Cellular & molecular immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Akt isoforms in the immune system.Frontiers in immunology · 2022
    Review
  17. Plasticity of Innate Lymphoid Cells in Cancer.Frontiers in immunology · 2022
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Yan LiDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China.ORCID http://orcid.org/0000-0001-6061-2170
Shihao ChenDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China.
Yafei ChiDepartment of Laboratory Animal Sciences, Capital Medical University, Beijing, China.
Yiran YangDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China.
Xiwen ChenDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China.
Huating WangDepartment of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University and Beijing Institute of Respiratory Medicine, Beijing, China.
Zhe LvDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China.
Jingjing WangDepartment of Laboratory Animal Sciences, Capital Medical University, Beijing, China.
Linjie YuanDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China.
Ping HuangDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China.
Kewu HuangDepartment of Respiratory and Critical Care Medicine, Beijing Chao-Yang Hospital, Capital Medical University and Beijing Institute of Respiratory Medicine, Beijing, China.
Chris J CorriganFaculty of Life Sciences & Medicine, School of Immunology and Microbial Sciences, Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK.
Wei WangDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China. wy_robin@ccmu.edu.cn.
Sun YingDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, P.R. China. ying.sun@ccmu.edu.cn.
Capital Medical University · CNKing's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ILC2s are implicated in asthma pathogenesis, but little is known about the mechanisms underlying their accumulation in airways. We investigated the time course of ILC2 accumulation in different tissues in murine models of asthma induced by a serial per-nasal challenge with ovalbumin (OVA), house dust mice (HDM), IL-25 and IL-33 and explored the potential roles of ILC2-attracting chemokines in this phenomenon. Flow cytometry was used to enumerate ILC2s at various time points. The effects of cytokines and chemokines on ILC2 migration were measured in vitro using a chemotaxis assay and in vivo using small animal imaging. Compared with saline and OVA challenge, both IL-25 and IL-33 challenge alone induced significant accumulation of ILC2s in the mediastinal lymph nodes, lung tissue and bronchoalveolar lavage fluid of challenged animals, but with a distinct potency and kinetics. In vitro, IL-33 and CXCL16, but not IL-25 or CCL25, directly induced ILC2 migration. Small animal in vivo imaging further confirmed that a single intranasal provocation with IL-33 or CXCL16 was sufficient to induce the accumulation of ILC2s in the lungs following injection via the tail vein. Moreover, IL-33-induced ILC2 migration involved the activation of ERK1/2, p38, Akt, JNK and NF-κB, while CXCL16-induced ILC2 migration involved the activation of ERK1/2, p38 and Akt. These data support the hypothesis that epithelium-derived IL-25 and IL-33 induce lung accumulation of ILC2s, while IL-33 exerts a direct chemotactic effect in this process. Although ILC2s express the chemokine receptors CXCR6 and CCR9, only CXCL16, the ligand of CXCR6, exhibits a direct chemoattractant effect.

Indexed as

Immunity, InnateAnimalsAntibodiesAsthmaChemokine CXCL16ChemotaxisCytokinesDisease Models, AnimalFemaleInterleukin-17Interleukin-33KineticsLungLymphocytesMice, Inbred BALB CPyroglyphidaeAntibodiesChemokine CXCL16CytokinesInterleukin-17Interleukin-33Receptors, ChemokineAccumulationAsthmaChemokineIL-25IL-33ILC2s

Identifiers

PMID30467418
PMCPMC6318283
OpenAlexW2901634036

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.